← FDA DRUG APPROVALS

FDA ANDA · ANDA040626

PRIMIDONE

Sponsor: TP ANDA HOLDINGS

APPLICATION
ANDA040626
TYPE
ANDA
ORIGINAL APPROVAL
2005-09-29
LATEST ACTION
2010-12-23
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

PRIMIDONEPrescription
PRIMIDONE 50MG · TABLET · ORAL
PRIMIDONEPrescription
PRIMIDONE 250MG · TABLET · ORAL

Approval history

2010-12-23Labeling · Supplement 9AP
2010-12-10Labeling · Supplement 8AP
2010-05-20Labeling · Supplement 7AP
2005-09-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →